|
|
|
Volumn 83, Issue 3, 2012, Pages 305-307
|
|
Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOFAZIMINE;
DAPSONE;
HEMOGLOBIN;
LEPROSTATIC AGENT;
RIFAMPICIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BLOOD;
BLOOD EXAMINATION;
BRAZIL;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HEMATOCRIT;
HEMOLYSIS;
HEMOLYTIC ANEMIA;
HUMAN;
LEPROSY;
MALE;
METHODOLOGY;
MIDDLE AGED;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
ADOLESCENT;
ADULT;
AGED;
ANEMIA, HEMOLYTIC;
BRAZIL;
CLOFAZIMINE;
DAPSONE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEMATOCRIT;
HEMATOLOGIC TESTS;
HEMOGLOBINS;
HEMOLYSIS;
HUMANS;
LEPROSTATIC AGENTS;
LEPROSY;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RIFAMPIN;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
YOUNG ADULT;
|
|
EID: 84873249363
PISSN: 03057518
EISSN: None
Source Type: None
DOI: None Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|
